| PERIOD ENDING | 3-Jan-09 | 29-Dec-07 | 30-Dec-06 | | Total Revenue | 74,042 | 71,875 | 34,013 | | Cost of Revenue | 41,055 | 38,263 | 17,549 | | | Gross Profit | 32,987 | 33,612 | 16,464 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 30,124 | 34,283 | 28,163 | | Non Recurring | 18,367 |
-
| 2,043 | | Others |
-
| 3,612 | 686 | | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (15,504) | (4,283) | (14,428) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 673 | 1,998 | 2,110 | | Earnings Before Interest And Taxes | (14,831) | (2,285) | (12,318) | | Interest Expense |
-
|
-
|
-
| | Income Before Tax | (14,831) | (2,285) | (12,318) | | Income Tax Expense | (6) | 52 | 52 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (14,825) | (2,337) | (12,370) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (14,825) | (2,337) | (12,370) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($14,825) | ($2,337) | ($12,370) |
|
0.29% Nasdaq 
Income Statement
